Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Review
  • Published:

Cellular immune response to HTLV-1

Oncogene volume 24, pages 6035–6046 (2005)Cite this article

Abstract

There is strong evidence at the individual level and the population level that an efficient cytotoxic T lymphocyte (CTL) response to HTLV-1 limits the proviral load and the risk of associated inflammatory diseases such as HAM/TSP. This evidence comes from host population genetics, viral genetics, DNA expression microarrays and assays of lymphocyte function. However, until now there has been no satisfactory and rigorous means to define or to measure the efficiency of an antiviral CTL response. Recently, methods have been developed to quantify lymphocyte turnover rates in vivo and the efficiency of anti-HTLV-1 CTLs ex vivo. Data from these new techniques appear to substantiate the conclusion that variation between individual hosts in the rate at which a single CTL kills HTLV-1-infected lymphocytes is an important determinant, perhaps the decisive determinant, of the proviral load and the risk of HAM/TSP. With these experimental data, it is becoming possible to refine, parameterize and test mathematical models of the immune control of HTLV-1, which are a necessary part of an understanding of this complex dynamic system.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Box 1

Similar content being viewed by others

References

  • Arnulf B, Thorel M, Poirot Y, Tamouza R, Boulanger E, Jaccard A, Oksenhendler E, Hermine O and Pique C . (2004). Leukemia, 18, 126–132.

  • Asquith B and Bangham CR . (2003). Proc. Roy. Soc. London. B. Biol. Sci., 270, 1651–1657.

  • Asquith B, Debacq C, Macallan DC, Willems L and Bangham CR . (2002). Trends Immunol., 23, 596–601.

  • Asquith B, Hanon E, Taylor GP and Bangham CR . (2000). Philos. Trans. Roy. Soc. London. B. Biol. Sci., 355, 1013–1019.

  • Asquith B, Mosley AJ, Barfield A, Marshall SEF, Heaps AG, Goon PKC, Hanon E, Tanaka Y, Taylor GP and Bangham CRM . (2005). J. Gen. Virol., 86, 1515–1523.

  • Bangham CR . (2003). J. Gen. Virol., 84, 3177–3189.

  • Bangham CRM, Kermode AG, Hall SE and Daenke S . (1996). Sem. Virol, 7, 41–48.

  • Betts MR, Ambrozak DR, Douek DC, Bonhoeffer S, Brenchley JM, Casazza JP, Koup RA and Picker LJ . (2001). J. Virol., 75, 11983–11991.

  • Borducchi DM, Gerbase-DeLima M, Morgun A, Shulzhenko N, Pombo-de-Oliveira MS, Kerbauy J and Rodrigues de Oliveira JS . (2003). Br. J. Haematol., 123, 954–955.

  • Braud VM, Allan DS, O’Callaghan CA, Soderstrom K, D’Andrea A, Ogg GS, Lazetic S, Young NT, Bell JI, Phillips JH, Lanier LL and McMichael AJ . (1998). Nature, 391, 795–799.

  • Cavrois M, Gessain A, Wain-Hobson S and Wattel E . (1996). Oncogene, 12, 2419–2423.

  • Cosman D, Mullberg J, Sutherland CL, Chin W, Armitage R, Fanslow W, Kubin M and Chalupny NJ . (2001). Immunity, 14, 123–133.

  • Daenke S and Bangham CR . (1994). Clin. Exp. Immunol., 96, 179–181.

  • Daenke S, Nightingale S, Cruickshank JK and Bangham CR . (1990). J. Virol., 64, 1278–1282.

  • Eiraku N, Hingorani R, Ijichi S, Machigashira K, Gregersen PK, Monteiro J, Usuku K, Yashiki S, Sonoda S, Osame M and Hall WW . (1998). J. Immunol., 161, 6674–6680.

  • Elovaara I, Koenig S, Brewah AY, Woods RM, Lehky T and Jacobson S . (1993). J. Exp. Med., 177, 1567–1573.

  • Etoh K, Tamiya S, Yamaguchi K, Okayama A, Tsubouchi H, Ideta T, Mueller N, Takatsuki K and Matsuoka M . (1997). Cancer Res., 57, 4862–4867.

  • Fujihara K, Itoyama Y, Yu F, Kubo C and Goto I . (1991). J. Neurol. Sci., 105, 99–107.

  • Furukawa Y, Kubota R, Tara M, Izumo S and Osame M . (2001). Blood, 97, 987–993.

  • Furukawa Y, Yamashita M, Usuku K, Izumo S, Nakagawa M and Osame M . (2000). J. Infect Dis., 182, 1343–1349.

  • Gaudray G, Gachon F, Basbous J, Biard-Piechaczyk M, Devaux C and Mesnard JM . (2002). J. Virol., 76, 12813–12822.

  • Gessain A, Louie A, Gout O, Gallo RC and Franchini G . (1991). J. Virol., 65, 1628–1633.

  • Goon PK, Hanon E, Igakura T, Tanaka Y, Weber JN, Taylor GP and Bangham CR . (2002). Blood, 99, 3335–3341.

  • Goon PK, Igakura T, Hanon E, Mosley AJ, Asquith B, Gould KG, Taylor GP, Weber JN and Bangham CR . (2003). J. Virol., 77, 9716–9722.

  • Goon PK, Igakura T, Hanon E, Mosley AJ, Barfield A, Barnard AL, Kaftantzi L, Tanaka Y, Taylor GP, Weber JN and Bangham CR . (2004a). J. Immunol., 172, 1735–1743.

  • Goon PKC, Biancardi A, Fast N, Igakura T, Hanon E, Mosley A, Asquith B, Gould KG, Marshall S, Taylor GP and Bangham CRM . (2004b). J. Infect. Dis., 189, 2294–2298.

  • Greten TF, Slansky JE, Kubota R, Soldan SS, Jaffee EM, Leist TP, Pardoll DM, Jacobson S and Schneck JP . (1998). Proc. Natl. Acad. Sci. USA, 95, 7568–7573.

  • Groh V, Rhinehart R, Randolph-Habecker J, Topp MS, Riddell SR and Spies T . (2001). Nat. Immunol., 2, 255–260.

  • Hanon E, Hall S, Taylor GP, Saito M, Davis R, Tanaka Y, Usuku K, Osame M, Weber JN and Bangham CR . (2000a). Blood, 95, 1386–1392.

  • Hanon E, Stinchcombe JC, Saito M, Asquith BE, Taylor GP, Tanaka Y, Weber JN, Griffiths GM and Bangham CR . (2000b). Immunity, 13, 657–664.

  • Harashima N, Kurihara K, Utsunomiya A, Tanosaki R, Hanabuchi S, Masuda M, Ohashi T, Fukui F, Hasegawa A, Masuda T, Takaue Y, Okamura J and Kannagi M . (2004). Cancer Res., 64, 391–399.

  • Hidaka M, Inoue J, Yoshida M and Seiki M . (1988). EMBO J., 7, 519–523.

  • Higuchi I, Hashimoto K, Matsuoka E, Rosales R, Nakagawa M, Arimura K, Izumo S and Osame M . (1996). Acta. Neuropathol. (Berlin), 92, 358–361.

  • Hisada M, Stuver SO, Okayama A, Li HC, Sawada T, Hanchard B and Mueller NE . (2004). J. Infect. Dis., 190, 1605–1609.

  • Igakura T, Stinchcombe JC, Goon PK, Taylor GP, Weber JN, Griffiths GM, Tanaka Y, Osame M and Bangham CR . (2003). Science, 299, 1713–1716.

  • Ijichi S, Izumo S, Eiraku N, Machigashira K, Kubota R, Nagai M, Ikegami N, Kashio N, Umehara F, Maruyama I and Osame M . (1993). Med. Hypotheses, 41, 542–547.

  • Ishihara S, Okayama A, Stuver S, Horinouchi H, Shioiri S, Murai K, Kubota T, Yamashita R, Tachibana N, Tsubouchi H and Mueller N . (1994). J. Acquir. Immune Defic. Syndr., 7, 199–203.

  • Iwasaki Y . (1993). Brain Pathol., 3, 1–10.

  • Iwasaki Y, Ohara Y, Kobayashi I and Akizuki S . (1992). Am. J. Pathol., 140, 1003–1008.

  • Jacobson S . (2002). J. Infect. Dis., 186 (Suppl 2), S187–S192.

  • Jacobson S, McFarlin DE, Robinson S, Voskuhl R, Martin R, Brewah A, Newell AJ and Koenig S . (1992). Ann. Neurol., 32, 651–657.

  • Jacobson S, Shida H, McFarlin DE, Fauci AS and Koenig S . (1990). Nature, 348, 245–248.

  • Jeffery KJ, Siddiqui AA, Bunce M, Lloyd AL, Vine AM, Witkover AD, Izumo S, Usuku K, Welsh KI, Osame M and Bangham CR . (2000). J. Immunol., 165, 7278–7284.

  • Jeffery KJ, Usuku K, Hall SE, Matsumoto W, Taylor GP, Procter J, Bunce M, Ogg GS, Welsh KI, Weber JN, Lloyd AL, Nowak MA, Nagai M, Kodama D, Izumo S, Osame M and Bangham CR . (1999). Proc. Natl. Acad. Sci. USA, 96, 3848–3853.

  • Kannagi M, Harada S, Maruyama I, Inoko H, Igarashi H, Kuwashima G, Sato S, Morita M, Kidokoro M and Sugimoto M (1991). Int. Immunol., 3, 761–767.

  • Kannagi M, Sugamura K, Kinoshita K, Uchino H and Hinuma Y . (1984). J. Immunol., 133, 1037–1041.

  • Kannagi M, Sugamura K, Sato H, Okochi K, Uchino H and Hinuma Y . (1983). J. Immunol., 130, 2942–2946.

  • Kazanji M, Moreau JP, Mahieux R, Bonnemains B, Bomford R, Gessain A and de The G . (1997). Virology, 231, 258–266.

  • Kinoshita T, Tsujimoto A and Shimotohno K . (1991). Int. J. Cancer, 47, 491–495.

  • Kira J, Nakamura M, Sawada T, Koyanagi Y, Ohori N, Itoyama Y, Yamamoto N, Sakaki Y and Goto I . (1992). J. Neurol. Sci., 107, 98–104.

  • Kitze B, Usuku K, Yamano Y, Yashiki S, Nakamura M, Fujiyoshi T, Izumo S, Osame M and Sonoda S . (1998). Clin. Exp. Immunol., 111, 278–285.

  • Kodama D, Saito M, Matsumoto W, Sabouri AH, Izumo S, Arimura K, Usuku K, Bangham CR and Osame M . (2004). J. Neuroimmunol., 156, 188–194.

  • Komurian F, Pelloquin F and de The G . (1991). J. Virol., 65, 3770–3778.

  • Kubota R, Kawanishi T, Matsubara H, Manns A and Jacobson S . (2000a). J. Neuroimmunol., 102, 208–215.

  • Kubota R, Nagai M, Kawanishi T, Osame M and Jacobson S . (2000b). AIDS Res. Hum. Retroviruses, 16, 1705–1709.

  • Lehky TJ, Fox CH, Koenig S, Levin MC, Flerlage N, Izumo S, Sato E, Raine CS, Osame M and Jacobson S . (1995). Ann. Neurol., 37, 167–175.

  • Lemasson I, Polakowski NJ, Laybourn PJ and Nyborg JK . (2004). Mol. Cell. Biol., 24, 6117–6126.

  • Levin MC, Lee SM, Kalume F, Morcos Y, Dohan Jr FC, Hasty KA, Callaway JC, Zunt J, Desiderio D and Stuart JM . (2002). Nat. Med., 8, 509–513.

  • Macallan DC, Asquith B, Irvine AJ, Wallace DL, Worth A, Ghattas H, Zhang Y, Griffin GE, Tough DF and Beverley PC . (2003). Eur. J. Immunol., 33, 2316–2326.

  • Macallan DC, Fullerton CA, Neese RA, Haddock K, Park SS and Hellerstein MK . (1998). Proc. Natl. Acad. Sci. USA, 95, 708–713.

  • Matsuoka E, Takenouchi N, Hashimoto K, Kashio N, Moritoyo T, Higuchi I, Isashiki Y, Sato E, Osame M and Izumo S . (1998). Acta. Neuropathol. (Berl.), 96, 340–346.

  • McGinn TM, Wei Q, Stallworth J and Fultz PN . (2004). AIDS Res. Hum. Retroviruses, 20, 443–456.

  • Moritoyo T, Izumo S, Moritoyo H, Tanaka Y, Kiyomatsu Y, Nagai M, Usuku K, Sorimachi M and Osame M . (1999). J. Neurovirol., 5, 241–248.

  • Nagai M, Usuku K, Matsumoto W, Kodama D, Takenouchi N, Moritoyo T, Hashiguchi S, Ichinose M, Bangham CR, Izumo S and Osame M . (1998). J. Neurovirol., 4, 586–593.

  • Nagasato K, Nakamura T, Shirabe S, Shibayama K, Ohishi K, Ichinose K, Tsujihata M and Nagataki S . (1991). J. Neurol. Sci., 103, 203–208.

  • Nicot C, Dundr M, Johnson JM, Fullen JR, Alonzo N, Fukumoto R, Princler GL, Derse D, Misteli T and Franchini G . (2004). Nat. Med., 10, 197–201.

  • Niewiesk S and Bangham CR . (1996). J. Mol. Evol., 42, 452–458.

  • Niewiesk S, Daenke S, Parker CE, Taylor G, Weber J, Nightingale S and Bangham CR . (1994). J. Virol., 68, 6778–6781.

  • Niewiesk S, Daenke S, Parker CE, Taylor G, Weber J, Nightingale S and Bangham CR . (1995). J. Virol., 69, 2649–2653.

  • Nishimura Y, Okubo R, Minato S, Itoyama Y, Goto I, Mori M, Hirayama K and Sasazuki T . (1991). Tissue Antigens, 37, 230–231.

  • Nomura M, Ohashi T, Nishikawa K, Nishitsuji H, Kurihara K, Hasegawa A, Furuta RA, Fujisawa J, Tanaka Y, Hanabuchi S, Harashima N, Masuda T and Kannagi M . (2004). J. Virol., 78, 3827–3836.

  • Nowak MA and Bangham CR . (1996). Science, 272, 74–79.

  • Ogg GS, Jin X, Bonhoeffer S, Dunbar PR, Nowak MA, Monard S, Segal JP, Cao Y, Rowland-Jones SL, Cerundolo V, Hurley A, Markowitz M, Ho DD, Nixon DF and McMichael AJ . (1998). Science, 279, 2103–2106.

  • Overbaugh J and Bangham CR . (2001). Science, 292, 1106–1109.

  • Parker CE, Daenke S, Nightingale S and Bangham CR . (1992). Virology, 188, 628–636.

  • Parker CE, Nightingale S, Taylor GP, Weber J and Bangham CR . (1994). J. Virol., 68, 2860–2868.

  • Pende D, Cantoni C, Rivera P, Vitale M, Castriconi R, Marcenaro S, Nanni M, Biassoni R, Bottino C, Moretta A and Moretta L . (2001). Eur. J. Immunol., 31, 1076–1086.

  • Pique C, Ureta-Vidal A, Gessain A, Chancerel B, Gout O, Tamouza R, Agis F and Dokhelar MC . (2000). J. Exp. Med., 191, 567–572.

  • Plancoulaine S, Gessain A, Joubert M, Tortevoye P, Jeanne I, Talarmin A, de The G and Abel L . (2000). J. Infect. Dis., 182, 405–412.

  • Rafatpanah H, Pravica V, Farid R, Abbaszadegan MR, Tabatabaei A, Goharjoo A, Etemadi MM and Hutchinson IV . (2004). Hum. Immunol., 65, 839–846.

  • Sabouri AH, Saito M, Lloyd AL, Vine AM, Witkover AW, Furukawa Y, Izumo S, Arimura K, Marshall SE, Usuku K, Bangham CR and Osame M . (2004). J. Infect. Dis., 190, 1279–1285.

  • Sabouri AH, Saito M, Usuku K, Bajestan SN, Mahmoudi M, Forughipour M, Sabouri Z, Abbaspour Z, Goharjoo ME, Khayami E, Hasani A, Izumo S, Arimura K, Farid R and Osame M . (2005). J. Gen. Virol., 86, 773–781.

  • Saito M, Braud VM, Goon P, Hanon E, Taylor GP, Saito A, Eiraku N, Tanaka Y, Usuku K, Weber JN, Osame M and Bangham CR . (2003). Blood, 102, 577–584.

  • Slattery JP, Franchini G and Gessain A . (1999). Genome Res., 9, 525–540.

  • Smith MJ, Gitlin SD, Browning CM, Lane BR, Clark NM, Shah N, Rainier S and Markovitz DM . (2001). J. Virol., 75, 2301–2313.

  • Sonoda S, Fujiyoshi T and Yashiki S . (1996). J. Acquir. Immune Defic. Syndr. Hum. Retrovirol., 13 (Suppl 1), S119–S123.

  • Sutherland CL, Chalupny NJ, Schooley K, VandenBos T, Kubin M and Cosman D . (2002). J. Immunol., 168, 671–679.

  • Usuku K, Nishizawa M, Matsuki K, Tokunaga K, Takahashi K, Eiraku N, Suehara M, Juji T, Osame M and Tabira T . (1990). Eur. J. Immunol., 20, 1603–1606.

  • Utsunomiya A, Miyazaki Y, Takatsuka Y, Hanada S, Uozumi K, Yashiki S, Tara M, Kawano F, Saburi Y, Kikuchi H, Hara M, Sao H, Morishima Y, Kodera Y, Sonoda S and Tomonaga M . (2001). Bone Marrow Transplant., 27, 15–20.

  • Vine AM, Heaps AG, Kaftantzi L, Mosley A, Asquith B, Witkover A, Thompson G, Saito M, Goon PK, Carr L, Martinez-Murillo F, Taylor GP and Bangham CR . (2004). J. Immunol., 173, 5121–5129.

  • Vine AM, Witkover AD, Lloyd AL, Jeffery KJ, Siddiqui A, Marshall SE, Bunce M, Eiraku N, Izumo S, Usuku K, Osame M and Bangham CR . (2002). J. Infect. Dis., 186, 932–939.

  • Wodarz D and Bangham CR . (2000). J. Mol. Evol., 50, 448–455.

  • Wodarz D, Hall SE, Usuku K, Osame M, Ogg GS, McMichael AJ, Nowak MA and Bangham CR . (2001). Proc. Roy. Soc. London B. Biol. Sci., 268, 1215–1221.

  • Yu F, Itoyama Y, Fujihara K and Goto I . (1991). J. Neuroimmunol., 33, 121–128.

Download references

Acknowledgements

We thank the following for comments: B Asquith, Y Furukawa, P Goon, A Mosley, M Saito and R Kubota. This work was supported by the Wellcome Trust UK, The Leukaemia Research Fund (UK) and the Program for Promotion of Fundamental Studies in Health Science of the Organization for Pharmaceutical Safety and Research (Japan).

Author information

Authors and Affiliations

  1. Department of Immunology, Imperial College, St Mary's Campus, Norfolk Place, London, W2 1PG, UK

    Charles R M Bangham

  2. Third Department of Internal Medicine, University Hospital, Faculty of Medicine, Kagoshima University, 8-35-1 Sakuragaoka, Kagoshima, 890-8520, Japan

    Mitsuhiro Osame

Authors
  1. Charles R M Bangham
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Mitsuhiro Osame
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Charles R M Bangham.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bangham, C., Osame, M. Cellular immune response to HTLV-1. Oncogene 24, 6035–6046 (2005). https://doi.org/10.1038/sj.onc.1208970

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1208970

Keywords

This article is cited by

Search

Advanced search

Quick links